Status:
COMPLETED
Comparison of the Effects of Sugammadex and Neostigmine on Early Extubation, Intensive Care Unit Admission and Length of Stay, and Hospital Costs in Adult Cranial Surgery
Lead Sponsor:
Kanuni Sultan Suleyman Training and Research Hospital
Conditions:
Craniectomy
Sugammadex
Eligibility:
All Genders
19+ years
Brief Summary
The aim of this study was to retrospectively investigate the effects of sugammadex or neostigmine, which are routinely used after the completion of surgery to antagonize (reverse) neuromuscular blocka...
Eligibility Criteria
Inclusion
- Patients from the American Society of Anesthesiology (ASA) I-II-III group,
- over the age of 18,
- who underwent elective surgery,
- underwent general anesthesia with sevoflurane anesthesia from volatile anesthetics,
- used rocuronium as a neuromuscular blocking agent
Exclusion
- Patients aged 18 and under,
- ASA IV and above,
- who underwent surgery under emergency conditions,
- who have incomplete follow-up form records and electronic media data,
- who were taken to the intensive care unit without neuromuscular blockade antagonism due to long surgery,
- who were treated with a neuromuscular blocking agent other than rocuronium,
- who were treated with a volatile anesthetic other than sevoflurane or with total intravenous anesthesia.
Key Trial Info
Start Date :
May 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 31 2021
Estimated Enrollment :
112 Patients enrolled
Trial Details
Trial ID
NCT06987357
Start Date
May 1 2021
End Date
July 31 2021
Last Update
May 23 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kanuni Sultan Suleyman Training and Research Hospital
Istanbul, Turkey (Türkiye)